Vitamin D3 as adjunctive therapy in the treatment of depression in tuberculosis patients: a short-term pilot randomized double-blind controlled study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Objective: We aimed to evaluate whether high-dose cholecalciferol has beneficial effects on depression in pulmonary tuberculosis (PTB) patients. Methods: This pilot, randomized, and double-blind trial enrolled 123 recurrent PTB patients (aged ≥18 years) meeting Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria of major depressive disorder from four hospitals in Southeast China. Patients were randomly assigned to 8-week oral treatment with 100,000 IU/week cholecalciferol (Vit D group) or a matching placebo (control group). The primary outcome was treatment response, defined as a 50% reduction in symptoms and change in scores of the Chinese version of Beck Depression Inventory (BDI) from baseline to 8 weeks. Relative risks of depression were estimated using multivariable logistic regression. Results: Finally, 120 patients were enrolled, including 56 test patients and 64 controls. After 8 weeks, the treatment response or BDI scores did not differ significantly between groups. Multivariate logistic regression showed that BDI scores were not significantly improved in the Vit D group after adjustment for age, time to first negative smear, or 25-hydroxyvitamin D level. Conclusion: The use of high-dose Vit D3 supplementation may not be warranted for reducing depressive symptoms in the PTB population. Nevertheless, this finding should be validated by further large-scale studies according to different kinds of depression or Vit D receptor polymorphism genotype. Keywords: vitamin D, major depressive disorders, depression, tuberculosis, Mycobacterium tuberculosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only one study31 had a low risk of bias score on all the items on Cochrane tool for the assessment of intervention studies, the rest were classified as having high risk of bias.”
From Pharmacological or non-pharmacological interventions for treatment of common mental disorders associated with Tuberculosis: A systematic review (2021) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Two articles evaluated pharmacological interventions (antidepressants and Vitamin D).”
From Pharmacological or non-pharmacological interventions for treatment of common mental disorders associated with Tuberculosis: A systematic review (2021) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression Is the Leading Cause of Disability Around the World
Friedrich, M. J. (2017) · JAMA · doi:10.1001/jama.2017.3826 · Cited by 1,459 · cited 1×
“4% since 2005.(5) Both depressive disorders and subthreshold depressive symptoms substantially threaten health and economy.”
BackgroundDepression, Disability Days, and Days Lost From Work in a Prospective Epidemiologic Survey
Broadhead, W. E. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450190056028 · Cited by 1,237 · cited 1×
“Both depressive disorders and subthreshold depressive symptoms substantially threaten health and economy.(6,7) Depression in PTB individuals is associated with delayed sought of health care and poor treatment compliance, which can lead to drug resistance, morbidity, and mortality.”
BackgroundKaton, W., Lin, E. H. B., & Kroenke, K. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.11.005 · Cited by 965 · cited 1×
“Finally, no evidence suggests that TB and depression may share risk factors.(38,39) Immunological responses have been implicated in the association between chronic disease and depression.”
BackgroundEpidemiology and treatment of depression in patients with chronic medical illness
J. Katon, W. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/wkaton · Cited by 820
Vitamin D deficiency and depression in adults: systematic review and meta-analysis
Anglin, R. E. S., Samaan, Z., Walter, S. D., & McDonald, S. D. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.106666 · Cited by 820
Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis
Nnoaham, K. E., & Clarke, A. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym247 · Cited by 681 · cited 1×
“Tuberculosis (TB) patients are at an increased risk of 25-hydroxyvitamin D (25(OH)D) deficiency compared with the general population.(9,10) Several randomized trials report the effectiveness or safety of vitamin D (Vit D) supplementation to standard TB treatment, but bring about conflicting findings.”
BackgroundEfficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level
Vieth, R., Chan, P.-C. R., & MacFarlane, G. D. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.288 · Cited by 616 · cited 1×
“However, the existing studies are limited by the use of unrepresentative samples (Alzheimer’s disease, Parkinson’s disease or psychiatric disorders), different diagnostic tools for quantification of depressive symptoms, co-interventions (eg, calcium or psychotropic drugs), and insufficient doses (,2,000 IU daily) to a…”
BackgroundMartineau, A. R., Timms, P. M., Bothamley, G. H., Hanifa, Y., Islam, K., Claxton, A. P., Packe, G. E., Moore-Gillon, J. C., Darmalingam, M., Davidson, R. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61889-2 · Cited by 580
Depression and immune function
Kiecolt-Glaser, J. K., & Glaser, R. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00309-4 · Cited by 571 · cited 2×
“Finally, no evidence suggests that TB and depression may share risk factors.(38,39) Immunological responses have been implicated in the association between chronic disease and depression.”
BackgroundFloyd, K., Glaziou, P., Zumla, A., & Raviglione, M. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30057-2 · Cited by 440 · cited 1×
“Background Pulmonary tuberculosis (PTB), a chronic infectious disease, was the second major cause of death worldwide in 2016.(1) PTB patients are faced with higher rates of comorbid depression compared with the general population.”
BackgroundWejse, C., Gomes, V. F., Rabna, P., Gustafson, P., Aaby, P., Lisse, I. M., Andersen, P. L., Glerup, H., & Sodemann, M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-567oc · Cited by 395
Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review
Mikkelsen, R. L., Middelboe, T., Pisinger, C., & Stage, K. B. (2004) · Nordic Journal of Psychiatry · doi:10.1080/08039480310000824 · Cited by 345 · cited 2×
“In addition, TB patients may develop depression as a result of chronic infection or related psychosocioeconomic stressors.(36) Finally, no evidence suggests that TB and depression may share risk factors.”
BackgroundDepression, disability days, and days lost from work in a prospective epidemiologic survey
Broadhead, W. E. (1990) · JAMA · doi:10.1001/jama.264.19.2524 · Cited by 289
Ew, N., Amin, Z., & Rumende, C. M. (2006) · PubMed · Cited by 270
Gowda, U., Mutowo, M. P., Smith, B. J., Wluka, A. E., & Renzaho, A. M. N. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.017 · Cited by 229
Shaffer, J. A., Edmondson, D., Wasson, L. T., Falzon, L., Homma, K., Ezeokoli, N., Li, P., & Davidson, K. W. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000044 · Cited by 227 · cited 1×
“Two systematic reviews and meta-analyses based on RCTs showed that low Vit D concentration is associated with depression(20) and Vit D supplementation may be effective in reducing symptoms of clinically significant depression.(33) A recent meta-analysis(34) suggested that Vit D supplementation favorably impacted depre…”
BackgroundThe effects of vitamin D on brain development and adult brain function
Kesby, J. P., Eyles, D. W., Burne, T. H. J., & McGrath, J. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.05.014 · Cited by 220 · cited 1×
“brain function via immunomodulation, anti-inflammation, and neuroplasticity promotion.(18,19) As for the effects of Vit D supplementation on depressive symptoms, recent metaanalyses of observational studies(20) and randomized controlled trials (RCTs)(21) reported that depressive symptoms were not associated with 25(OH…”
BackgroundPharmacokinetics of a single, large dose of cholecalciferol
Ilahi, M., Armas, L. A., & Heaney, R. P. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.688 · Cited by 201 · cited 1×
“However, the existing studies are limited by the use of unrepresentative samples (Alzheimer’s disease, Parkinson’s disease or psychiatric disorders), different diagnostic tools for quantification of depressive symptoms, co-interventions (eg, calcium or psychotropic drugs), and insufficient doses (,2,000 IU daily) to a…”
BackgroundPachi, A., Bratis, D., Moussas, G., & Tselebis, A. (2013) · Tuberculosis Research and Treatment · doi:10.1155/2013/489865 · Cited by 185 · cited 1×
“Depression in PTB individuals is associated with delayed sought of health care and poor treatment compliance, which can lead to drug resistance, morbidity, and mortality.(8) Tuberculosis (TB) patients are at an increased risk of 25-hydroxyvitamin D (25(OH)D) deficiency compared with the general population.”
BackgroundDean, A. J., Bellgrove, M. A., Hall, T., Phan, W. M. J., Eyles, D. W., Kvaskoff, D., & McGrath, J. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025966 · Cited by 180
A review of the interplay between tuberculosis and mental health
Doherty, A. M., Kelly, J., McDonald, C., O’Dywer, A. M., Keane, J., & Cooney, J. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.03.018 · Cited by 179
Egede, L. E., Acierno, R., Knapp, R. G., Lejuez, C., Hernandez-Tejada, M., Payne, E. H., & Frueh, B. C. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00122-4 · Cited by 177 · cited 1×
“Treatment responders for BDI II were those with at least 50% improvement of total score from baseline ([baseline – post]/baseline $50%).(26) BDI II consists of 21 self-reported items, and each item is rated on a scale of 0–3, producing a possible score from 0 to 63.”
MethodFall prevention and vitamin D in the elderly: an overview of the key role of the non-bone effects
Annweiler, C., Montero‐Odasso, M., Schott, A., Berrut, G., Fantino, B., & Beauchet, O. (2010) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/1743-0003-7-50 · Cited by 171 · cited 1×
“brain function via immunomodulation, anti-inflammation, and neuroplasticity promotion.(18,19) As for the effects of Vit D supplementation on depressive symptoms, recent metaanalyses of observational studies(20) and randomized controlled trials (RCTs)(21) reported that depressive symptoms were not associated with 25(OH…”
BackgroundMood disorders and complementary and alternative medicine: a literature review
Qureshi, N. A., & Al-Bedah (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s43419 · Cited by 155 · cited 1×
“Vit D is also a neurosteroid with fast non-genomic effects and genomic effect, which could be beneficial for mood disorders.(16) Animal and experimental studies show that Vit D receptor interacts with glucocorticoid receptors in the hippocampus(17) and 1,25(OH)2D3 promotes synthesis of monoamine neurotransmitters (eg,…”
BackgroundVDR gene variants associate with cognitive function and depressive symptoms in old age
Kuningas, M., Mooijaart, S. P., Jolles, J., Slagboom, P. E., Westendorp, R. G. J., & van Heemst, D. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.001 · Cited by 149 · cited 1×
“Third, we did not test the polymorphism of the Vit D receptor, genetic variance of which influences the susceptibility to age-related changes in cognitive functioning and depressive symptoms.(41) Fourth, the sample size was relatively small, since some statistics (P-value) for the results are critical.”
ResultCross‐talk of vitamin D and glucocorticoids in hippocampal cells
Obradovic, D., Gronemeyer, H., Lutz, B., & Rein, T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03579.x · Cited by 144
Daley, P., Jagannathan, V., John, K. R., Sarojini, J., Latha, A., Vieth, R., Suzana, S., Jeyaseelan, L., Christopher, D. J., Smieja, M., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70053-8 · Cited by 138 · cited 1×
“However, Daley et al found inconsistent results without testing such polymorphism.(11) Vit D, an essential nutrient for bone health, also performs other physiological functions such as anti-inflammation, antiproliferation, antibacterial action, prodifferentiation, and immunomodulation.”
ResultVellekkatt, F., & Menon, V (2019) · Journal of Postgraduate Medicine · doi:10.4103/jpgm.jpgm_571_17 · Cited by 136
Loosman, W. L., Rottier, M. A., Honig, A., & Siegert, C. E. H. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0149-7 · Cited by 134
Koyanagi, A., Vancampfort, D., Carvalho, A. F., DeVylder, J. E., Haro, J. M., Pizzol, D., Veronese, N., & Stubbs, B. (2017) · BMC Medicine · doi:10.1186/s12916-017-0975-5 · Cited by 131
Husain, M. O., Dearman, S. P., Chaudhry, I. B., Rizvi, N., & Waheed, W. (2008) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-4-4 · Cited by 130
Pietrzak, R. H., Kinley, J., Afifi, T. O., Enns, M. W., Fawcett, J., & Sareen, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712002309 · Cited by 127 · cited 1×
“Both depressive disorders and subthreshold depressive symptoms substantially threaten health and economy.(6,7) Depression in PTB individuals is associated with delayed sought of health care and poor treatment compliance, which can lead to drug resistance, morbidity, and mortality.”
BackgroundArvold, D. S., Odean, M. J., Dornfeld, M. P., Regal, R. R., Arvold, J. G., Karwoski, G. C., Mast, D. J., Sanford, P. B., & Sjoberg, R. J. (2009) · Endocrine Practice · doi:10.4158/ep.15.3.203 · Cited by 110
Ambaw, F., Mayston, R., Hanlon, C., & Alem, A. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007653 · Cited by 75 · cited 1×
“The pathways for the TB and depression associations are probably complex and multidirectional.(35) First, under chronic pulmonary conditions, hypoxia can directly make patients anxious and depressed.”
BackgroundWang, Y., Liu, Y., Lian, Y., Li, N., Liu, H., & Li, G. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000486 · Cited by 56 · cited 1×
“Second, like in most previous studies, we did not survey vascular depression, which could benefit from high-dose oral Vit D3 supplementation.(32) Third, we did not test the polymorphism of the Vit D receptor, genetic variance of which influences the susceptibility to age-related changes in cognitive functioning and de…”
ResultVitamin D intake and lung cancer risk in the Women’s Health Initiative
Cheng, T. D., LaCroix, A. Z., Beresford, S. A. A., Goodman, G. E., Thornquist, M. D., Zheng, Y., Chlebowski, R. T., Ho, G. Y. F., & Neuhouser, M. L. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.055905 · Cited by 47 · cited 2×
“Dietary intake at both baseline and over the 8 weeks was assessed by a self-administered food-frequency questionnaire specifically for Women’s Health Initiative.24 The participants were asked to abstain from consuming Vit D-/Ca-containing foods during the study period based on a standard questionnaire.25 Neuropsychiat…”
MethodInterpreting Vitamin D Assay Results: Proceed with Caution
Jones, G. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05490614 · Cited by 44 · cited 1×
“Plasma 25(OH)D (Vit D2 + Vit D3) levels were measured using liquid chromatography–tandem mass spectrometry.(29)”
MethodRequirements for Vitamin D Across the Life Span
Grant, W. B., & Boucher, B. J. (2011) · Biological Research For Nursing · doi:10.1177/1099800410391243 · Cited by 36 · cited 1×
“Vit D, an essential nutrient for bone health, also performs other physiological functions such as anti-inflammation, antiproliferation, antibacterial action, prodifferentiation, and immunomodulation.(15) Vit D is also a neurosteroid with fast non-genomic effects and genomic effect, which could be beneficial for mood d…”
BackgroundGong, Y., Yan, S., Qiu, L., Zhang, S., Lu, Z., Tong, Y., Fang, P., & Yin, X. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0840 · Cited by 24
Shaffer, J. A., Edmondson, D. E., Wasson, L. T., Falzon, L., Homma, K., Ezeokoli, N., Li, P. C.-W., & Davidson, K. W. (2014) · Psychosomatic Medicine · doi:10.7916/d8xg9r16 · Cited by 21
Sezer, S., Uyar, M. E., Bal, Z., Tutal, E., & Özdemir, F. N. (2013) · Clinical Nephrology · doi:10.5414/cn107742 · Cited by 20 · cited 1×
“A BDI II score $11 indicates the presence of depressive symptoms,(27) and a larger score indicates higher severity.(28) Diagnosis and severity of depression for each patient were determined independently by two experienced psychiatrists through structured interviews.”
MethodBazzano, A. N., Littrell, L. N., Lambert, S., & Roi, C. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s122979 · Cited by 13 · cited 1×
“Tuberculosis (TB) patients are at an increased risk of 25-hydroxyvitamin D (25(OH)D) deficiency compared with the general population.(9,10) Several randomized trials report the effectiveness or safety of vitamin D (Vit D) supplementation to standard TB treatment, but bring about conflicting findings.”
BackgroundImpact of vitamin D supplementation on adiposity in African-Americans
Chandler, P. D., Scott, J. B., Drake, B. F., Ng, K., Chan, A. T., Hollis, B. W., Emmons, K. M., Giovannucci, E. L., Fuchs, C. S., & Bennett, G. G. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2014.44 · Cited by 11 · cited 1×
“The participants were asked to abstain from consuming Vit D-/Ca-containing foods during the study period based on a standard questionnaire.(25)”
MethodErratum: Impact of vitamin D supplementation on adiposity in African-Americans
Chandler, P. D., Scott, J. B., Drake, B. F., Ng, K., Chan, A. T., Hollis, B. W., Emmons, K. M., Giovannucci, E. L., Fuchs, C. S., & Bennett, G. G. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2015.14 · Cited by 4
Cited by
Jamilian, H., Amirani, E., Milajerdi, A., Kolahdooz, F., Mirzaei, H., Zaroudi, M., Ghaderi, A., & Asemi, Z. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109651 · Cited by 139
Mikola, T., Marx, W., Lane, M. M., Hockey, M., Loughman, A., Rajapolvi, S., Rocks, T., O'Neil, A. E., Mischoulon, D., Valkonen‐Korhonen, M., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2096560 · Cited by 102
“In single studies, adverse events such as bone and joint pain, nausea, diarrhea, and itching led to discontinuation of five (Wang et al. 2016) and two (Zhang et al. 2018) participants from the vitamin D group.”
BackgroundInfluentialXie, F., Huang, T., Lou, D., Fu, R., Ni, C., Hong, J., & Ruan, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.903547 · Cited by 76
Meng, J., Li, X., Xiong, Y., Wu, Y., Liu, P., & Gao, S. (2024) · Infection · doi:10.1007/s15010-024-02446-z · Cited by 43
“8 studies [7, 9, 22, 24, 28, 33, 35] administered vitamin D weekly, with weekly dosages ranging from 50,000 IU to 140,000 IU.”
Farooq, S., Tunmore, J., & Comber, R. (2021) · Chronic Respiratory Disease · doi:10.1177/14799731211003937 · Cited by 31
“Two studies evaluated pharmacological interventions.(31,32) Table 1 describes the characteristics of the final included studies in this review, including; author, year, country, setting, population, method, design and sample characteristics.”
BackgroundMethod
Metadata
- Authors
- Zhang, L., Wang, S., Zhu, Y., & Yang, T.
- Affiliations
- Ningbo No. 2 Hospital (CN)
- Ningbo Center for Disease Control and Prevention (CN)
- Corresponding author
- Yang, Tianchi
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2018-11
- Volume
- Volume 14
- Pages
- 3103-3109
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC6241718
- OpenAlex
- W2900822211
- Cited by
- 16
- References
- 44
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2019: 2
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- vitamin D3, depression, pulmonary tuberculosis, major depressive disorder, adjunctive therapy, high-dose vitamin D supplementation, Beck Depression Inventory, 25-hydroxyvitamin D, tuberculosis relapse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
